Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapy

Fig. 2

Early tumor shrinkage (ETS) distribution among patients with different responses to immunotherapy for hepatocellular carcinoma. A. Waterfall plot displays the ETS and treatment response, according to mRECIST, for each patient; B. Boxplot illustrates the ETS in each mRECIST patient group; mRECIST: modified response evaluation criteria in solid tumors; PR: partial response; SD: stable disease; PD: progressive disease

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us